Press

Intervacc AB (publ) announces today that its European distribution partner, Dechra Pharmaceuticals PLC (“Dechra”), is launching Strangvac^® in Spain, Portugal and Slovenia. Vials of the vaccine against the ... Read more

Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Wednesday 14 May 2025, at which the following resolutions were made.

Intervacc AB (publ) announces today that its distribution partner, Dechra Pharmaceuticals PLC ("Dechra"), will launch Strangvac^® in Finland and vaccine vials are expected to be available for delivery shortly. ... Read more

The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held on Wednesday 14 May 2025 at 3.00 p.m. at Cirio Advokatbyrå, ... Read more